Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$391M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$376M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$361M |
| 4 |
Johnson & Johnson
JNJ
|
+$258M |
| 5 |
Procter & Gamble
PG
|
+$175M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$536M |
| 2 |
X
US Steel
X
|
+$421M |
| 3 |
NVIDIA
NVDA
|
+$375M |
| 4 |
Deere & Co
DE
|
+$226M |
| 5 |
JPMorgan Chase
JPM
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.92% |
| 2 | Financials | 18.53% |
| 3 | Industrials | 12.39% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Healthcare | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Nautilus Biotechnolgy
NAUT
$215M
| $399K | ﹤0.01% |
550,740
-109,178
| -17% | -$82K |
|
3027
Tyra Biosciences
TYRA
$1.82B
| $399K | ﹤0.01% |
41,681
+6,969
| +20% | +$66.2K |
|
|
ACCS
3028
ACCESS Newswire
ACCS
$25.5M
| $398K | ﹤0.01% |
32,333
+1,103
| +4% | +$10.6K |
|
|
IROQ
3029
DELISTED
IF Bancorp
IROQ
| $397K | ﹤0.01% |
16,115
+942
| +6% | +$22.8K |
|
3030
Sundial Growers
SNDL
$325M
| $397K | ﹤0.01% |
328,065
-11,689
| -3% | -$15.6K |
|
3031
Broadwind
BWEN
$113M
| $391K | ﹤0.01% |
215,869
| – | – |
|
3032
Varonis Systems
VRNS
$5.25B
| $390K | ﹤0.01% |
7,685
-142,489
| -95% | -$6.48M |
|
3033
Zentalis Pharmaceuticals
ZNTL
$308M
| $390K | ﹤0.01% |
335,966
-111,434
| -25% | -$147K |
|
|
TECX
3034
Tectonic Therapeutic
TECX
$573M
| $387K | ﹤0.01% |
19,498
-12,663
| -39% | -$257K |
|
|
MODV
3035
DELISTED
ModivCare
MODV
| $387K | ﹤0.01% |
123,916
-114,533
| -48% | -$211K |
|
3036
Flexible Solutions
FSI
$63.9M
| $382K | ﹤0.01% |
78,781
+7,800
| +11% | +$32.7K |
|
3037
Grupo SIMEC
SIM
$4.07B
| $381K | ﹤0.01% |
14,111
+53
| +0.4% | +$1.42K |
|
|
GOCO
3038
DELISTED
GoHealth
GOCO
| $379K | ﹤0.01% |
68,228
+40,657
| +147% | +$322K |
|
3039
Oramed Pharmaceuticals
ORMP
$165M
| $376K | ﹤0.01% |
166,899
+25,818
| +18% | +$56.9K |
|
3040
Immersion
IMMR
$216M
| $375K | ﹤0.01% |
47,579
-12,762
| -21% | -$94.9K |
|
3041
Nektar Therapeutics
NKTR
$2.39B
| $372K | ﹤0.01% |
14,380
-10,530
| -42% | -$118K |
|
3042
Eledon Pharmaceuticals
ELDN
$276M
| $370K | ﹤0.01% |
136,456
+20,281
| +17% | +$60.8K |
|
|
TSE
3043
DELISTED
Trinseo
TSE
| $369K | ﹤0.01% |
118,126
+14,153
| +14% | +$46.7K |
|
3044
Gray Media Inc
GTN.A
$709M
| $367K | ﹤0.01% |
33,800
| – | – |
|
3045
Pliant Therapeutics
PLRX
$67.5M
| $367K | ﹤0.01% |
315,887
-195,831
| -38% | -$277K |
|
3046
Bioceres Crop Solutions
BIOX
$21.9M
| $365K | ﹤0.01% |
81,671
| – | – |
|
3047
Comstock Holding Companies
CHCI
$152M
| $364K | ﹤0.01% |
36,071
+1,005
| +3% | +$9.98K |
|
3048
CuriosityStream
CURI
$139M
| $354K | ﹤0.01% |
63,130
+15,067
| +31% | +$69.2K |
|
3049
Urban One Class D
UONEK
$22.9M
| $354K | ﹤0.01% |
56,054
-13,223
| -19% | -$79.1K |
|
3050
Envela
ELA
$536M
| $350K | ﹤0.01% |
57,264
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Dimensional Fund Advisors held 3,373 positions worth $432B, up 7.4% from $402B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.6%. Dimensional Fund Advisors opened 53 new positions and exited 101, leaving the 3,373-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q2 2025 buy was Ralliant Corp: 965,437 shares worth $46.9M.
- Dimensional Fund Advisors added most to Capital One in Q2 2025, an estimated $391M increase.
- Dimensional Fund Advisors's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $375M.
- Dimensional Fund Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $536M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $432B portfolio in Q2 2025.
- Dimensional Fund Advisors opened 53 new positions and closed 101 in Q2 2025.
- Dimensional Fund Advisors's portfolio value rose 7.4% quarter-over-quarter to $432B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.